e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Pulmonary circulation I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Longitudinal assessment in combined pulmonary fibrosis and emphysema (CPFE): a case series
A. A. Stanziola, E. Carpentieri, C. Russo, C. Vitale, D. Radicella, B. Stanzione, M. Sofia (Naples, Italy)
Source:
Annual Congress 2009 - Pulmonary circulation I
Session:
Pulmonary circulation I
Session type:
Thematic Poster Session
Number:
3904
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. A. Stanziola, E. Carpentieri, C. Russo, C. Vitale, D. Radicella, B. Stanzione, M. Sofia (Naples, Italy). Longitudinal assessment in combined pulmonary fibrosis and emphysema (CPFE): a case series. Eur Respir J 2009; 34: Suppl. 53, 3904
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
CPFE (combined pulmonary fibrosis and emphysema): A case series
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2014 – ILDs 1
Year: 2014
Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
Source: ERJ Open Res, 5 (1) 00014-2018; 10.1183/23120541.00014-2018
Year: 2019
Autoimmunity profile in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Longitudinal structural changes using MDCT in patients with combined pulmonary fibrosis with emphysema
Source: Virtual Congress 2021 – Imaging
Year: 2021
Longitudinal assessment of lung fibrosis by micro CT correlates with histological evaluation in bleomycin-induced mice
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema
Source: ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021
Year: 2021
Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
Clinical features of combined pulmonary fibrosis and emphysema
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Acute exacerbation in combined pulmonary fibrosis and emphysema (CPFE): what special features?
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020
Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF treatment II
Year: 2016
The impact of emphysema in pulmonary fibrosis
Source: Eur Respir Rev 2013; 22: 153-157
Year: 2013
Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis
Source: ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020
Year: 2020
Ifigenia study on
N
-acetylcystine in idiopathic pulmonary fibrosis (IPF): comparison of HRCT and lung biopsy
Source: Eur Respir J 2001; 18: Suppl. 33, 527s
Year: 2001
Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011
Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Clinical significance of combined pulmonary fibrosis and emphysema
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept